Baker Bros. Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Baker Bros. Advisors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-522,360	Closed	-$1.11M	–	135
2020 Q4	$1.11M	Sell	522,360 -58,040	-10%	-$95.7K	﹤0.01%	117
2020 Q3	$679K	Hold	580,400	–	–	﹤0.01%	115
2020 Q2	$525K	Hold	580,400	–	–	﹤0.01%	109
2020 Q1	$486K	Hold	580,400	–	–	﹤0.01%	105
2019 Q4	$557K	Hold	580,400	–	–	﹤0.01%	96
2019 Q3	$598K	Hold	580,400	–	–	﹤0.01%	102
2019 Q2	$1.04M	Hold	580,400	–	–	0.01%	95
2019 Q1	$1.09M	Hold	580,400	–	–	0.01%	89
2018 Q4	$685K	Hold	580,400	–	–	0.01%	86
2018 Q3	$1.57M	Hold	580,400	–	–	0.01%	88
2018 Q2	$1.11M	Hold	580,400	–	–	0.01%	107
2018 Q1	$1.22M	Hold	580,400	–	–	0.01%	98
2017 Q4	$1.18M	Hold	580,400	–	–	0.01%	106
2017 Q3	$772K	Hold	580,400	–	–	0.01%	110
2017 Q2	$911K	Hold	580,400	–	–	0.01%	101
2017 Q1	$1.88M	Hold	580,400	–	–	0.02%	91
2016 Q4	$784K	Hold	580,400	–	–	0.01%	114
2016 Q3	$905K	Buy	+580,400	New	+$892K	0.01%	116
2015 Q2	–	Sell	-305,037	Closed	-$4.26M	–	132
2015 Q1	$4.26M	Sell	305,037 -6,988	-2%	-$107K	0.04%	80
2014 Q4	$5.27M	Hold	312,025	–	–	0.05%	72
2014 Q3	$4.19M	Sell	312,025 -312,025	-50%	-$3.72M	0.05%	68
2014 Q2	$7.95M	Hold	624,050	–	–	0.1%	51
2014 Q1	$7.42M	Buy	+624,050	New	+$8.37M	0.09%	57
2013 Q4	–	Sell	-586,936	Closed	-$10.2M	–	98
2013 Q3	$10.2M	Sell	586,936 -429,497	-42%	-$8.22M	0.15%	42
2013 Q2	$16.5M	Buy	+1,016,433	New	+$31.5M	0.33%	32

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

TLP

Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

GPC

Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Baker Bros. Advisors's INFI Position: Q1 2021 in Review

Baker Bros. Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2021, closing a stake of 522,360 shares — an estimated $1.11M sold.

Baker Bros. Advisors first reported a position in INFI in Q2 2013 and held it in 25 quarters. The position peaked at $16.5M in Q2 2013. 83 funds tracked by Wall St. Rank hold INFI as of Q1 2021.

Baker Bros. Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Baker Bros. Advisors sold 522,360 Infinity Pharmaceuticals, Inc. shares in Q1 2021, an estimated $1.11M.
Baker Bros. Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 25 quarters.
Baker Bros. Advisors's Infinity Pharmaceuticals, Inc. position peaked at $16.5M in Q2 2013.
83 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2021.

Based on Baker Bros. Advisors's 13F filing for Q1 2021, filed 17 May 2021.